Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.03% |
| 2 | Technology | 14.98% |
| 3 | Consumer Discretionary | 11.43% |
| 4 | Consumer Staples | 10.71% |
| 5 | Communication Services | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Seanergy Maritime Holdings
SHIP
$363M
| $3.22M | ﹤0.01% |
282,728
+210,330
| +291% | +$2.28M |
|
|
AMTI
1877
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $3.22M | ﹤0.01% |
428,200
+254,600
| +147% | +$2.11M |
|
1878
Vanguard Communication Services ETF
VOX
$5.9B
| $3.19M | ﹤0.01% |
26,600
+25,000
| +1,563% | +$3.06M |
|
1879
Ecovyst
ECVT
$1.14B
| $3.18M | ﹤0.01% |
274,700
+88,042
| +47% | +$923K |
|
|
PPBI
1880
DELISTED
Pacific Premier Bancorp
PPBI
| $3.18M | ﹤0.01% |
89,834
+46,106
| +105% | +$1.79M |
|
1881
ProShares Short 20+ Year Treasury ETF
TBF
$107M
| $3.17M | ﹤0.01% |
+179,400
| New | +$3.07M |
|
1882
GATX Corp
GATX
$6.38B
| $3.17M | ﹤0.01% |
25,700
-5,300
| -17% | -$579K |
|
1883
Red Rock Resorts
RRR
$3.76B
| $3.17M | ﹤0.01% |
65,200
-169,100
| -72% | -$8.06M |
|
1884
Syndax Pharmaceuticals
SNDX
$1.77B
| $3.17M | ﹤0.01% |
+182,100
| New | +$3.07M |
|
1885
Sensus Healthcare
SRTS
$47.1M
| $3.16M | ﹤0.01% |
312,134
+150,200
| +93% | +$1.37M |
|
1886
Flywire
FLYW
$2.29B
| $3.15M | ﹤0.01% |
+102,900
| New | +$2.93M |
|
1887
Varex Imaging
VREX
$779M
| $3.14M | ﹤0.01% |
147,580
-23,300
| -14% | -$592K |
|
1888
TriMas Corp
TRS
$1.4B
| $3.14M | ﹤0.01% |
97,870
+28,500
| +41% | +$951K |
|
1889
Curis
CRIS
$3.76M
| $3.14M | ﹤0.01% |
3,296
+2,203
| +202% | +$2.81M |
|
1890
Northrim BanCorp
NRIM
$606M
| $3.13M | ﹤0.01% |
287,200
+52,000
| +22% | +$575K |
|
|
CD
1891
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
| $3.13M | ﹤0.01% |
494,900
+88,600
| +22% | +$489K |
|
|
AQUA
1892
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $3.12M | ﹤0.01% |
66,500
+30,632
| +85% | +$1.31M |
|
|
EVOP
1893
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $3.12M | ﹤0.01% |
135,000
+95,700
| +244% | +$2.27M |
|
|
RFP
1894
DELISTED
Resolute Forest Products Inc.
RFP
| $3.11M | ﹤0.01% |
241,000
+201,400
| +509% | +$2.71M |
|
1895
US Physical Therapy
USPH
$1.21B
| $3.11M | ﹤0.01% |
31,234
-36,389
| -54% | -$3.47M |
|
1896
Marten Transport
MRTN
$1.24B
| $3.1M | ﹤0.01% |
174,850
+142,018
| +433% | +$2.49M |
|
1897
Republic Bancorp
RBCAA
$1.92B
| $3.1M | ﹤0.01% |
69,100
+10,100
| +17% | +$483K |
|
1898
Schrodinger
SDGR
$1.32B
| $3.1M | ﹤0.01% |
+90,900
| New | +$2.76M |
|
|
CVLY
1899
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $3.1M | ﹤0.01% |
141,005
-23,200
| -14% | -$511K |
|
1900
Standard Motor Products
SMP
$870M
| $3.1M | ﹤0.01% |
71,800
+8,000
| +13% | +$375K |
|
Similar funds
Jim Simons's Q1 2022 Portfolio in Review
As of Q1 2022, Jim Simons held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Jim Simons's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Jim Simons added most to Tesla in Q1 2022, an estimated $759M increase.
- Jim Simons's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Jim Simons fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Jim Simons's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Jim Simons opened 822 new positions and closed 650 in Q1 2022.
- Jim Simons's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.